CRC
JUNO

Curi RMB Capital’s Juno Therapeutics, Inc. JUNO Stock Holding History

Curi RMB Capital’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-87,815
Closed -$4.01M – 1011
2017
Q4 		$4.01M Buy
87,815
+27,725
+46% +$1.38M 0.1% 265
2017
Q3 		$2.7M Buy
+60,090
New +$2.05M 0.07% 328

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Curi RMB Capital's JUNO Position: Q1 2018 in Review

Curi RMB Capital sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 87,815 shares — an estimated $4.01M sold.

Curi RMB Capital first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $4.01M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Curi RMB Capital reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Curi RMB Capital sold 87,815 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $4.01M.
  • Curi RMB Capital first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Curi RMB Capital's Juno Therapeutics, Inc. position peaked at $4.01M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Curi RMB Capital's 13F filing for Q1 2018, filed 14 May 2018.